Sundaram Long Term Tax Advantage Fund Series III vs UTI Series III: NAV, Returns and Maturity Status Compared

Sundaram Long Term Tax Advantage Fund Series III vs UTI Series III comes down to one key fact before any number matters: only one of these two schemes is still active today. In Sundaram Long Term Tax Advantage Fund Series III vs UTI Series III, Sundaram Series III continues to publish a daily NAV, which stands at Rs 32.75 for the Direct Plan Growth option per the latest AMFI data, while UTI Series III matured in 2021 and paid out its investors at a final NAV of Rs 23.29.

That single difference shapes what Sundaram Long Term Tax Advantage Fund Series III vs UTI Series III means for you. If you hold units of Sundaram Series III, you have a live decision to make about redeeming or holding until maturity. If you invested in UTI Series III, your money has already come back, and the useful question that Sundaram Long Term Tax Advantage Fund Series III vs UTI Series III raises is what the scheme’s track record teaches you about close ended ELSS products.

Click Here – Get Free Investment Predictions

Sundaram Long Term Tax Advantage Fund Series III vs UTI Series III: Quick Comparison Table

The table below sets out Sundaram Long Term Tax Advantage Fund Series III vs UTI Series III on structure, NAV and verified returns computed from official AMFI NAV history.

Parameter	Sundaram Series III	UTI Series III
Fund house	Sundaram Mutual Fund	UTI Mutual Fund
Category	Close ended ELSS (10 year tenure)	Close ended ELSS
Units allotted	2018	2016
Current status	Live, matures in 2028	Matured in 2021
NAV (Direct Plan Growth)	Rs 32.75 (latest AMFI NAV)	Rs 23.29 (final NAV)
NAV (Regular Plan Growth)	Rs 31.66 (latest AMFI NAV)	Rs 22.08 (final NAV)
CAGR since launch (Direct)	15.36% per year	16.62% per year (over full life)
Total return since launch (Direct)	About 227%	About 132% at maturity
Lock in	3 years (already over)	3 years (scheme closed)
Fresh investment allowed	No, NFO only scheme	No, scheme has matured

Sundaram Long Term Tax Advantage Fund Series III vs UTI Series III: NAV and Live Performance

The Sundaram side of Sundaram Long Term Tax Advantage Fund Series III vs UTI Series III has compounded investor money at 15.36 percent per year since units were allotted in 2018, turning the Rs 10 NFO price into a current NAV of Rs 32.75. That is a total gain of about 227 percent in a little over eight years for Direct Plan Growth investors.

The medium term numbers in Sundaram Long Term Tax Advantage Fund Series III vs UTI Series III remain healthy for the live fund. Based on AMFI NAV history, Sundaram Series III has delivered a 5 year CAGR of 18.76 percent and a 3 year CAGR of 16.41 percent. The 1 year return is a more modest 9.45 percent, reflecting broader consolidation in Indian equities rather than anything specific to this scheme.

The UTI side of Sundaram Long Term Tax Advantage Fund Series III vs UTI Series III no longer publishes a live NAV. This close ended ELSS from UTI Mutual Fund allotted units at Rs 10 in 2016, ran for roughly five and a half years, and declared its final NAV of Rs 23.29 for the Direct Plan Growth option in 2021. The Regular Plan Growth option closed at Rs 22.08.

Use the Univest Screener to Compare Live Fund and Stock Data

Sundaram Long Term Tax Advantage Fund Series III vs UTI Series III: Maturity and Investment Status

Structurally, the Sundaram fund in Sundaram Long Term Tax Advantage Fund Series III vs UTI Series III is a ten year close ended ELSS. It accepted money only during its 2018 new fund offer, gave investors Section 80C tax benefits, and imposed a three year lock in. Since that lock in ended, unitholders have been free to redeem on any business day at NAV, and any units still outstanding will be compulsorily redeemed when the scheme matures in 2028.

The UTI fund in Sundaram Long Term Tax Advantage Fund Series III vs UTI Series III has already completed this full cycle. Its full life record was strong: the scheme compounded at about 16.62 percent per year, delivering a total return of roughly 132 percent to Direct Plan investors who stayed from allotment to maturity. Investors also collected the Section 80C tax deduction on their original investment, which pushes the effective post tax outcome higher than the headline number in Sundaram Long Term Tax Advantage Fund Series III vs UTI Series III suggests.

Sundaram Long Term Tax Advantage Fund Series III vs UTI Series III: Which Fund Performed Better

On pure lifetime CAGR, Sundaram Long Term Tax Advantage Fund Series III vs UTI Series III tilts slightly toward UTI Series III, which finished at 16.62 percent per year versus 15.36 percent for Sundaram Series III so far. The UTI scheme also benefited from perfectly timed bookends, entering near the 2016 market lows and exiting into the strong post pandemic rally of late 2021.

Total wealth created flips the story in Sundaram Long Term Tax Advantage Fund Series III vs UTI Series III. Because Sundaram Series III has stayed invested for over eight years, its 227 percent cumulative gain is far larger than the 132 percent the UTI scheme locked in at maturity. A UTI investor who received Rs 23.29 per unit at maturity in 2021 also had to find a new home for that money, and reinvestment risk is a real cost that Sundaram Long Term Tax Advantage Fund Series III vs UTI Series III exposes but a maturity cheque quietly carries.

The honest verdict from Sundaram Long Term Tax Advantage Fund Series III vs UTI Series III is that both schemes did their job. Each one roughly doubled or tripled investor money, beat inflation comfortably, and delivered the tax deduction it promised. The bigger lesson from Sundaram Long Term Tax Advantage Fund Series III vs UTI Series III sits in the structure, not the scores.

Sundaram Long Term Tax Advantage Fund Series III vs UTI Series III: Key Takeaways for Tax Saving Investors

Close ended ELSS schemes, as Sundaram Long Term Tax Advantage Fund Series III vs UTI Series III shows, are a discontinued breed. You cannot add money after the NFO, you cannot run a SIP, and your exit at maturity may or may not land in a favourable market. Open ended ELSS funds solve all three problems while offering the same Section 80C benefit and the same three year lock in per instalment.

If you still hold Sundaram Series III, the Sundaram Long Term Tax Advantage Fund Series III vs UTI Series III comparison suggests reviewing it the way you would any equity fund. The lock in is over, so the choice between redeeming now at Rs 32.75 and holding until the 2028 maturity should rest on your goals, your tax situation on gains, and whether the money has a better destination. A SEBI registered investment adviser can help you weigh that call against your full portfolio.

Download the Univest iOS App or Univest Android App to track funds, stocks and SEBI registered research in one place.

Conclusion

Sundaram Long Term Tax Advantage Fund Series III vs UTI Series III ultimately favours neither fund outright. Sundaram Series III remains a live scheme with a verified NAV of Rs 32.75 and a 15.36 percent CAGR since its 2018 launch, while UTI Series III has already returned investor money at a lifetime CAGR of 16.62 percent. Neither side of Sundaram Long Term Tax Advantage Fund Series III vs UTI Series III accepts fresh money today, so for new tax saving investment in FY 2026-27, an open ended ELSS with a consistent track record is the practical route. Historically, disciplined ELSS investing has rewarded patience, but always consult a SEBI registered adviser before acting.

FAQs on Sundaram Long Term Tax Advantage Fund Series III vs UTI Series III

In Sundaram Long Term Tax Advantage Fund Series III vs UTI Series III, which fund is better?

Ans. On lifetime CAGR, UTI Series III finished slightly ahead at about 16.62 percent per year, versus 15.36 percent per year for Sundaram Series III so far. In Sundaram Long Term Tax Advantage Fund Series III vs UTI Series III, the Sundaram scheme has built a larger total corpus simply because it has stayed invested longer.

What is the latest NAV in Sundaram Long Term Tax Advantage Fund Series III vs UTI Series III?

Ans. The latest NAV of Sundaram Series III Direct Plan Growth is Rs 32.75 per official AMFI data. The Regular Plan Growth NAV stands at Rs 31.66 as of the same declaration.

Is UTI Series III still active in the Sundaram Long Term Tax Advantage Fund Series III vs UTI Series III comparison?

Ans. No. Within Sundaram Long Term Tax Advantage Fund Series III vs UTI Series III, the UTI scheme has already matured. Its final declared NAV was Rs 23.29 for the Direct Plan Growth option, declared in 2021, after which the scheme stopped publishing NAVs and proceeds were paid out to unitholders.

Can I invest in either fund from Sundaram Long Term Tax Advantage Fund Series III vs UTI Series III today?

Ans. No fresh investment is possible in either scheme covered in Sundaram Long Term Tax Advantage Fund Series III vs UTI Series III. Sundaram Series III is a close ended ELSS that accepted subscriptions only during its 2018 new fund offer, and UTI Series III has already matured and stopped accepting or holding investor money.

What type of fund is the Sundaram side of Sundaram Long Term Tax Advantage Fund Series III vs UTI Series III?

Ans. Sundaram Series III is a ten year close ended equity linked savings scheme, or ELSS, from Sundaram Mutual Fund. Investments made during its NFO qualified for Section 80C tax deduction and carried a three year lock in period.

What returns has the Sundaram fund delivered in Sundaram Long Term Tax Advantage Fund Series III vs UTI Series III?

Ans. Sundaram Series III Direct Plan Growth has returned about 9.45 percent over 1 year, 16.41 percent CAGR over 3 years and 18.76 percent CAGR over 5 years, per the latest AMFI NAV history. Since its 2018 launch, the fund has compounded at roughly 15.36 percent per year, a total gain of about 227 percent.

What happened to UTI Series III investors at maturity in Sundaram Long Term Tax Advantage Fund Series III vs UTI Series III?

Ans. At maturity, outstanding units of UTI Series III were compulsorily redeemed at the prevailing NAV and the proceeds were paid to unitholders. An investor who entered at the Rs 10 NFO price in 2016 received about Rs 23.29 per unit in the Direct Plan Growth option, a total return of roughly 132 percent.

What is the key takeaway from Sundaram Long Term Tax Advantage Fund Series III vs UTI Series III?

Ans. The key takeaway from Sundaram Long Term Tax Advantage Fund Series III vs UTI Series III is that close ended ELSS schemes cannot take fresh money after their NFO, so investors comparing them today should treat this as a case study rather than a live investment choice. An open ended ELSS fund with a consistent long term record is the practical route for new tax saving investment.